All | POBA | PCB | P-value | |
---|---|---|---|---|
3-month outcomes | ||||
N | 88 | 63 | 25 | |
Circuit primary patency, n (%) | 63 (71.6) | 46 (76.2) | 15 (60) | 0.209 |
Circuit primary assisted patency, n (%) | 82 (93.2) | 59 (93.7) | 23 (92) | 1.000 |
Target lesion patency, n (%) | 67 (76.1) | 50 (79.4) | 17 (68) | 0.395 |
6-month outcomes | ||||
N | 87 | 62 | 25 | |
Circuit primary patency, n (%) | 36 (41.4) | 27 (43.5) | 9 (36) | 0.685 |
Circuit primary assisted patency, n (%) | 74 (85.1) | 54 (87.1) | 20 (80) | 0.508 |
Target lesion patency, n (%) | 45 (51.7) | 32 (51.6) | 13 (52) | 1.000 |
12-month outcomes | ||||
N | 81 | 59 | 22 | |
Circuit primary patency, n (%) | 15 (18.5) | 13 (22) | 2 (9.1) | 0.219 |
Circuit primary assisted patency, n (%) | 63 (77.8) | 45 (76.3) | 18 (81.8) | 0.767 |
Target lesion patency, n (%) | 25 (30.9) | 20 (33.9) | 5 (22.7) | 0.485 |